Recent Drug Discovery Research for March 2025
Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Clinical Trial
| Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
| Global Next Generation Antibody Therapeutics Market Insights and Forecast to 2028
Topics: Antibody Technologies, Drug Discovery
Regions: Global
| Sickle Cell Disease with Vaso-Occlusive Crisis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Parkinson's Disease, Research & Development, Drug Discovery
| Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Pain, Drug Discovery, CNS/Neurology
| Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Gastritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Gastrointestinal
| Systemic Mastocytosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Irritable Bowel Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Gastrointestinal
| Peritonitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Nephrotic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Aplastic Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Blood Diseases, Drug Discovery
| Hypothyroidism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Vancomycin-Resistant Enterococcus Faecium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Impetigo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Dermatology
| Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Tuberculosis, Drug Discovery
| Leishmaniasis (Kala-Azar) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Infectious Diseases
| Hepatitis B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Hepatitis, Drug Discovery
| Cytomegalovirus (HHV-5) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Osteoarthritis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2031
Topics: Pain, Arthritis, Osteoporosis, Drug Discovery, Clinical Trial
| Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Topics: Drug Discovery, Clinical Trial, CNS/Neurology
| Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2021-2031
Topics: Drug Discovery, CNS/Neurology, Behavioral Health
| Atopic Dermatitis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020 - 2030
Topics: Drug Discovery, Clinical Trial, Dermatology
| Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: AIDS, HIV & STDs, Cancer Treatment, Drug Discovery, Oncology/Hematology
| Progressive Multifocal Leukoencephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Secondary (Hypogonadotropic) Hypogonadism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Diabetic Foot Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Diabetes, Drug Discovery
| Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Diabetes, Drug Discovery
| Type 1 Diabetes (Juvenile Diabetes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Diabetes, Drug Discovery
| Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Cardiovascular
| Heterozygous familial hypercholesterolemia (heFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Obesity, Drug Discovery
| Psoriatic Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Arthritis, Psoriasis, Drug Discovery
| Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Gouty Arthritis (Gout) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Arthritis, Drug Discovery
| Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Chondrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery
| Anaplastic Astrocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Gliosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, CNS/Neurology
| Neuroblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
|
Prev | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
